英语听力 | 流行性感冒

Vismita Gupta-Smith: We are talking about influenza today. How does the vaccine combat the influenza virus? How is the composition of the vaccine decided? And how does WHO track the influenza virus across the world?

Hello and welcome to Science in 5. I am Vismita Gupta-Smith. We are talking to Dr Sylvie Briand today. Welcome, Sylvie. Before we talk about influenza, speak to us, please Sylvie, about this spike in respiratory disease that we are seeing and the reasons for it.

Dr Sylvie Briand: Indeed, we are seeing a spike in respiratory viruses, all kind[s] of viruses, COVID 19, Influenza, RSV. And this is not a surprise. We always see an increase in respiratory diseases in winter time for the northern hemisphere. Why?

Firstly, because most of the 175 types of circulating respiratory viruses prefer cold and humid weather. Most of them produce mild disease, but some of them like COVID-19, influenza or RSV can produce severe disease, leading to hospitalization and even death. Secondly, when the weather is cold or humid, people tend to gather indoor, in less ventilated spaces and thus are more exposed to infection.

However, this year is a bit special. We are seeing more respiratory diseases than usual. We think that this increase is due to at least two factors:

In the past three years, people were applying personal protective measures like mask, washing hands, less gatherings. But this year, in many countries, most of these preventive measures are not applied anymore.

In addition, people have probably lost some of their immunity against respiratory viruses in general, given the low circulation of respiratory viruses in the past years thanks to the protective measures.

Vismita Gupta-Smith: Sylvie, talk to us about the influenza virus and how the vaccine combats it?

Dr Sylvie Briand: There are many influenza viruses circulating. We know at least three big families: AH1N1, AH3N2 and B viruses. What is important to know is that these viruses evolve constantly. As they multiply in human cells, viruses are changing. This is like having a “parent virus” making many children and then having many grandchildren and many great grandchildren.

The influenza vaccine, it’s like a picture of the virus – a picture of the enemy that is shown to our internal defenses, the antibodies. When the antibodies have seen the picture of the virus, they can recognize it. So when the virus enters the body, the antibody can push it out. This is how the influenza vaccine works.

However, because of the constant evolution of the virus, we need to update the influenza vaccine composition regularly, so that the picture of the enemy that is shown to the antibodies is not the picture of the parent virus that was circulating last year but the picture of the great grandchild viruses that are circulating this year.

Vismita Gupta-Smith: Sylvie, speak to us about how WHO tracks the influenza virus across the world? And how is the composition of the vaccine decided?

Dr Sylvie Briand: The WHO has a network of laboratories around the world called GISRS, the Global Influenza Surveillance and Response System. This network is composed of more than 150 laboratories in 137 countries. Those laboratories are collecting and monitoring influenza viruses throughout the year. The collected viruses at the national level are then sent regularly to WHO collaborating centers for global assessment. Experts meet regularly to monitor the circulating viruses, assess which ones are predominant and then define which ones should be considered for the vaccine, so that the picture of the enemy is the best possible picture to train our antibodies to fight the virus.

This represents an enormous amount of work. But many countries in the world are participating in this effort because influenza is an important public health issue and is killing between 200 to 600 thousand people every year, which represents nearly 8,000 deaths per week on average.

So the influenza vaccine is safe and very effective to protect against severe disease, hospitalizations and death. And it is strongly recommended for people at risk of severe disease such as elderly, people with underlying conditions and co-morbidities like immunosuppression, diabetes, chronic respiratory and cardiac diseases and so on. Influenza vaccine is also recommended for pregnant women and young children.

We also encourage health care workers to get vaccinated as they are more exposed to the virus in their professional practice, and they are less likely to infect their patients when vaccinated.

Vismita Gupta-Smith: Thank you, Sylvie. That was Science in 5 today. Until next time then, stay safe, stay health and stick with science.

每日听力合集：

【特 别 声明】本公众平台除特别注明原创或授权转载外，其他文章均为转载，版权归原作者或平台所有，出于传递信息之目的，并没有任何商业目的。 本公号尊重知识产权，如无意中侵犯了您的权益，请及时联系后台，本公号将及时删除。

合集收藏

备考专辑： & &

语音单词：& & &

新闻英语： & &&

歌曲TED: & & & &

美文故事: & & & &

名字外教： & & & & &

微信公众号改版，订阅号消息不再按时间排序，为了防止迷路，希望小可爱们可以动动小小手点个“在看”或者将“小芳老师”添加到★“星标”☆中！让系统知道这是你喜欢看的公众号，这样我们就可以一直就可以永远幸福在一起啊！